The Global ANCA Vasculitis Drug Market Size Was Valued at USD 468.89 Million in 2023 and is Projected to Reach USD 765.68 Million by 2032, Growing at a CAGR of 5.6% From 2024-2032. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis represents a group of rare, severe autoimmune diseases characterized by the inflammation and destruction of small-to-medium blood […]
Wo Markttrends auf informierte Entscheidungen treffen
Headline
Tag: ANCA Vasculitis Drug Growth
Back To Top